Dr. Emily Gilmore & ELECTRO-BOOST Team Awarded $3.25M NINDS Grant
Principal Investigators Dr. Emily Gilmore, MD (Yale), Dr. Kan Ding, MD (UTSW), and Dr. Eric Rosenthal, MD (Massachusetts General Hospital) have received a $3.25 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) for their project entitled: "ELECTRO-BOOST: Electroencephalography for cerebral trauma recovery and oxygenation."
$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.
Neurology Establishes Committee on Diversity and Inclusion
The Department of Neurology’s new Committee on Diversity and Inclusion convened for the first time on Friday, June 26, 2020. The committee’s purpose is to promote diversity within the department’s education, career development, and leadership initiatives.
Improving treatment for psychogenic seizures: “This is a group of patients that we are taking less seriously”
Tolchin designed a study - and is currently developing an app - using motivational interviewing (MI) as an intervention to improve treatment adherence in people with psychogenic non-epileptic seizures (PNES).Source: newswise
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
COVID-19: Expert Guidance on Treating Myasthenia Gravis and LEMS
In an effort to respond to concerns of patients based on available data, a panel of experts has published new guidelines for treating myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) in the setting of the novel coronavirus.Source: NeurologyToday
Dr. David Hafler Conducts APSA Webinar
David Hafler MD recently served on the panel of a webinar led by the American Physician Scientists Association (APSA). The webinar presented strategies to support early-career residents, fellows, and junior faculty, as well as insights into how this group is affected by the COVID-19 pandemic.
NICU & Stroke Team to Present, Receive Awards at International Stroke Conference
Researchers at the Yale School of Medicine’s Neurointensive Care Unit (NICU) and Stroke division will present new, scientific findings and receive several major awards at the International Stroke Conference in Los Angeles from February 19 – 21, 2020.